Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece

Figure 1

Progression-free (a) and overall survival (b) of patients receiving first-line chemotherapy according to the chemotherapy regimen. CAPOXIRI, oxaliplatin/irinotecan/capecitabine; FOLFIRINOX, oxaliplatin/irinotecan/leucovorin/5-fluorouracil.

(a)

(b)